New: Introducing the Finviz Crypto Map

Learn More

IDEX Q2 Earnings Surpass Estimates, Sales Increase Year Over Year

By Zacks Equity Research | July 30, 2025, 11:14 AM

IDEX Corporation’s IEX second-quarter 2025 adjusted earnings of $2.07 per share surpassed the Zacks Consensus Estimate of $2.00. The bottom line was relatively flat on a year-over-year basis. Management projected adjusted earnings to be in the band of $1.95-$2.05 per share in the quarter.

IEX’s Revenue Details

IDEX’s net sales of $865.4 million beat the Zacks Consensus Estimate of $857 million. The top line increased 7% year over year. Organic sales increased 1% year over year. While acquisitions/divestitures had a positive impact on sales of 5%, organic sales and foreign currency translation had a positive impact of 1% each on sales.

IEX reports net sales under three business segments, the results of which are discussed below:

Net sales from the Fluid & Metering Technologies segment totaled $310.9 million, down 3% year over year. Our estimate for segmental net sales was $312.2 million. Organic sales decreased 2% year over year. Acquisitions/divestitures had an adverse impact on sales of 2%, while foreign currency translation had a positive impact of 1% on sales.

Net sales from the Health & Science Technologies segment totaled $365.3 million, up 20% year over year. Our estimate for segmental net sales was $355.6 million. Organic sales increased 4% year over year. Acquisitions/divestitures and foreign currency translation had a positive impact of 15% and 1%, respectively, on sales.

Net sales from the Fire & Safety/Diversified Products segment totaled $191.5 million, which increased 3% year over year. Our estimate for segmental net sales was $188.4 million. Organic sales increased 2% on a year-over-year basis, while foreign currency translation had a favorable impact of 1% on sales.

IDEX Corporation Price, Consensus and EPS Surprise

IDEX Corporation Price, Consensus and EPS Surprise

IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote

IDEX’s Margin Profile

IDEX’s cost of sales increased 7.4% year over year to $473.2 million. The adjusted gross profit was $392.2 million, up 6.9% year over year. The adjusted gross margin was 45.3% compared with 45.4% in the year-ago quarter.

Selling, general and administrative expenses increased 11.4% year over year to $203.6 million. Adjusted EBITDA was $237.2 million, up 5.7% from the year-ago quarter figure. The adjusted EBITDA margin decreased 40 bps year over year to 27.4%.

The operating income was $187.9 million, up 2.8% year over year. The operating margin was 21.7%, down 90 bps year over year. Interest expenses (net) increased 92.6% year over year to $15.6 million.

Balance Sheet and Cash Flow of IDEX

While exiting the second quarter, IDEX’s cash and cash equivalents were $568.2 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.85 billion compared with $1.9 billion at the end of fourth-quarter 2024.

In the first six months of 2025, IDEX generated net cash of $267.4 million from operating activities, down 7.9% from the year-ago period. Capital expenditures were $29.1 million compared with $35.9 million in the first six months of 2024. In the same period, free cash flow was $238.3 million, down 6.3% year over year.

IDEX paid out dividends totaling $105.9 million in the first six months of 2025, up 5.2% year over year.

IDEX’s Outlook

For the third quarter, IDEX anticipates adjusted earnings to be in the band of $1.90-$1.95 per share.

On a GAAP basis, IEX predicts earnings to be in the range of $1.54-$1.61 per share. It expects organic sales to increase in the range of 2-3% from the year-ago reading.

For 2025, the company anticipates adjusted earnings to be in the range of $7.85-$7.95 per share. The figure indicates an increase from earnings of $7.89 per share reported in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.30-$6.44 per share.

Organic sales are predicted to increase approximately 1%.

IEX’s Zacks Rank & Other Key Picks

The company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Some other top-ranked companies are discussed below:

Flowserve Corporation FLS presently sports a Zacks Rank of 1. FLS’ earnings surpassed the consensus estimate twice and missed on the other two occasions in the trailing four quarters. The average earnings surprise was 5.5%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2025 earnings has increased 1.6%.

ITT Inc. ITT currently carries a Zacks Rank of 2. ITT has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 1.7%.  In the past 60 days, the Zacks Consensus Estimate for ITT’s 2025 earnings has increased 0.9%.

RBC Bearings RBC currently carries a Zacks Rank of 2. RBC outperformed the consensus estimate thrice in the preceding four quarters and missed once, with an average surprise of 4.7%.  In the past 60 days, the Zacks Consensus Estimate for RBC’s 2025 earnings has inched up 1.4%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
RBC Bearings Incorporated (RBC): Free Stock Analysis Report
 
Flowserve Corporation (FLS): Free Stock Analysis Report
 
ITT Inc. (ITT): Free Stock Analysis Report
 
IDEX Corporation (IEX): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News